Grayslake, IL, United States of America

Henry Q Zhang


 


Average Co-Inventor Count = 7.0

ph-index = 5

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2001-2011

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Henry Q Zhang

Introduction

Henry Q Zhang is a prominent inventor based in Grayslake, Illinois. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various health issues. With a total of 10 patents to his name, Zhang's work has the potential to impact the treatment of serious medical conditions.

Latest Patents

Zhang's latest patents include innovative compounds such as cyclobut-3-ene-1,2-dione inhibitors of polo-like kinases. These compounds are designed to inhibit polo-like kinases and are useful in treating diseases characterized by cellular proliferation, including cancer. Additionally, he has developed acetamides and benzamides that are effective in treating sexual dysfunction. These compounds are formulated to provide therapeutic benefits for individuals experiencing such conditions.

Career Highlights

Throughout his career, Henry Q Zhang has worked with notable organizations, including Abbott Laboratories Corporation and Northwestern University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Zhang has collaborated with esteemed colleagues such as William A Carroll and Mark W Holladay. These partnerships have further enhanced his research and development efforts, leading to the creation of impactful inventions.

Conclusion

Henry Q Zhang's innovative work in the pharmaceutical industry showcases his dedication to improving health outcomes through scientific advancements. His patents reflect a commitment to addressing critical medical challenges, making him a noteworthy figure in the realm of invention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…